Trial Profile
Induction therapy with decitabine and plerixafor priming for patients at least 60 years with acute myeloid leukemia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Decitabine (Primary) ; Plerixafor (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 11 Apr 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Apr 2018.
- 29 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 16 May 2011 New trial record